LUKE RODDY: Open Payments
NPI 1033963004 · GREELEY, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $249 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $68 |
| Lilly USA, LLC | 1 | $28 |
| BridgeBio Pharma, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| ABIOMED | 1 | $17 |
| CORDIS US CORP. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: BOTOX, ZEPBOUND, Attruby, QULIPTA, CAMZYOS, MYNX CONTROL, LEQVIO, UBRELVY.
Industry payments across CO — which companies pay providers there.
